Phase II and phase III failures: 2013–2015

• Models of the human heart for biomedical research: Opportunities and challenges

  2026 Physiological Reports article Medicine Tissue Engineering and Regenerative Medicine Open access

  3

  citations
• RNA-based therapeutic opportunities for the treatment of kidney diseases

  2025 Nature Reviews Nephrology review Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery

  8

  citations
• Structural perspectives on chemokine receptors

  2024 Biochemical Society Transactions article Biochemistry, Genetics and Molecular Biology Receptor Mechanisms and Signaling Open access

  17

  citations
• A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

  2024 Nature Biotechnology article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access

  333

  citations
• The translational value of ligand‐receptor binding kinetics in drug discovery

  2023 British Journal of Pharmacology article Biochemistry, Genetics and Molecular Biology Receptor Mechanisms and Signaling Open access

  27

  citations
• Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

  2021 Nature Communications article Medicine Parkinson's Disease Mechanisms and Treatments Open access cited by 1 patent

  209

  citations

6 results